Fortress Biotech, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fortress Biotech, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q2 2024.
  • Fortress Biotech, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Fortress Biotech, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $521K, a 16% increase year-over-year.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2023 was $521K, a 16% increase from 2022.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2022 was $449K, a 5.07% decline from 2021.
  • Fortress Biotech, Inc. annual Income Tax Expense (Benefit) for 2021 was $473K, a 5.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $521K $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $521K $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $521K $380K -$69K -15.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $590K $141K +$141K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $449K $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $449K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $449K $449K -$24K -5.07% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $473K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $473K $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $473K $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $473K $473K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2018 $944K +$944K Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $1.44M +$1.44M Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q4 2017 $1.51M $1.51M Oct 1, 2017 Dec 31, 2017 10-K 2018-03-16
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.